The Effect of Rosuvastatin and Olmesartan on the Progression of Coronary Atherosclerotic Disease
Clinical trial NCT02516826 · UNKNOWN
Trial details
- NCT number
- NCT02516826
- Sponsor
- Samsung Medical Center
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-01
- Primary completion
- 2018-08-01
- Enrollment
- 504
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.